Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(3):161-162; doi:10.1093/jnci/djj061
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mack, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mack, G. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

Clinical Trials Going to the Dogs: Canine Program To Study Tumor Treatment, Biology

George S. Mack

The first 10% of the full text of this article appears below.

After nearly 3 years of groundwork and planning, the Comparative Oncology Program (COP) at the National Cancer Institute took a step forward in February with the launch of a new canine clinical oncology trial. Although testing drugs in dogs is not a new concept, the $1.2 million program at the NCI's Center for Cancer Research incorporates an integrated approach to drug discovery and development by using technology based on knowledge of the recently sequenced dog genome, as well as many new efforts that have been designed to make the dog trials work much like drug studies done in humans.

The aims of the new approach are threefold: The first is to develop a set of reagents, including oligonucleotide microarrays and proteomic assays, to help predict . . . [Full Text of this Article]

The First Trial

A New Genomics Data Bank


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?